You just read:

University of Utah and Navigen Pharmaceuticals Announce a New Government Contract to Advance Slit2N for the Treatment of Hemorrhagic Fever and Anthrax Exposure

News provided by

Navigen Pharmaceuticals, Inc.

Dec 08, 2010, 03:50 EST